What is the recommended taper schedule for prednisone 60 mg once daily over a three‑week period in an adult without contraindicating conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisone 60mg Daily Taper Schedule Over 3 Weeks

For a 3-week prednisone taper starting at 60mg daily, reduce the dose by approximately 10mg every 4-7 days, tapering from 60mg to 40mg in week 1, 40mg to 20mg in week 2, and 20mg to 10mg or off by week 3, depending on the underlying condition and clinical response.

Standard 3-Week Taper Protocol

The most commonly recommended approach for a rapid taper from 60mg prednisone involves:

  • Week 1 (Days 1-7): 60mg daily for 4 days, then reduce to 40mg daily for 3 days 1
  • Week 2 (Days 8-14): 40mg daily for 4 days, then reduce to 20mg daily for 3 days 1
  • Week 3 (Days 15-21): 20mg daily for 4 days, then reduce to 10mg daily for 3 days 1

This schedule is derived from alcoholic hepatitis and autoimmune hepatitis treatment protocols where rapid tapers from high-dose steroids are well-established 1.

Alternative Structured Approach

For conditions requiring slightly more gradual reduction:

  • Days 1-4: 60mg daily 1
  • Days 5-8: 40mg daily 1
  • Days 9-12: 30mg daily 1
  • Days 13-16: 20mg daily 1
  • Days 17-21: 10mg daily 1

Critical Considerations for Tapering

Timing of dose administration: Give prednisone as a single morning dose to minimize hypothalamic-pituitary-adrenal axis suppression and improve adherence 1, 2. Divided doses are unnecessary for most conditions and increase side effect burden 2.

Disease-specific modifications: The taper rate should account for the underlying condition being treated. For autoimmune hepatitis, the initial 60mg dose is typically maintained for only 4 days before beginning reduction 1. For severe alcoholic hepatitis, a 28-day course at 40mg (not 60mg) is more standard, followed by a 2-week taper 1.

Monitoring during taper: Assess clinical response and laboratory markers (transaminases, inflammatory markers) at each dose reduction to detect early relapse 1. If symptoms recur during tapering, return to the previous effective dose rather than continuing the taper 1.

Common Pitfalls to Avoid

Avoid abrupt discontinuation: Even after 3 weeks of high-dose prednisone, stopping abruptly can precipitate adrenal insufficiency. The final week should taper to at least 10mg before considering complete cessation 1.

Do not use this schedule for chronic conditions: This rapid 3-week taper is appropriate only for acute inflammatory conditions. Autoimmune hepatitis, for example, requires months of therapy with much slower tapering (reducing by 5mg weekly from 20mg down to 10mg, then by 2.5mg increments) 1.

Recognize when slower tapering is needed: Patients with cirrhosis, elderly/frail patients, or those with multiple comorbidities may require more conservative dose reductions 1. In these cases, extend the taper to 4-6 weeks rather than 3 weeks.

Monitor for steroid-related complications: Even short courses at 60mg daily carry risk for hyperglycemia, hypertension, psychiatric symptoms, and infection 1. Initiate calcium (1000mg daily) and vitamin D (400-800 units daily) supplementation from day 1 1.

Special Populations

Hemodialysis patients: No dose adjustment is required, as prednisone is hepatically metabolized and not removed by dialysis 3. Use standard tapering schedules without supplemental dosing after dialysis sessions 3.

Patients requiring longer therapy: If clinical response is inadequate after 3 weeks, do not continue high-dose steroids without reassessing the diagnosis and considering steroid-sparing agents 1. Prolonged high-dose monotherapy (>18 months) significantly increases risk of osteoporosis, diabetes, and other serious complications 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prednisone Dosing in Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.